KDR and breast carcinoma: In order to investigate this important challenge, we used a technically sound IHC assay for VEGFR2 protein developed in our lab [14], and analyzed a large well-characterized primary breast cancer tissue cohort including various BRC subtypes (HR+, HER2+, TNBC).